Global Oncology Companion Diagnostic Market Research Report 2025(Status and Outlook)
Report Overview
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
This report provides a deep insight into the global Oncology Companion Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Companion Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Companion Diagnostic market in any manner.
Global Oncology Companion Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Inc.
Illumina
Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics
Inc.
bioM?rieux SA
Invivoscribe
Inc.
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others
Market Segmentation (by Application)
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncology Companion Diagnostic Market
Overview of the regional outlook of the Oncology Companion Diagnostic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Companion Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Companion Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
This report provides a deep insight into the global Oncology Companion Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Companion Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Companion Diagnostic market in any manner.
Global Oncology Companion Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Inc.
Illumina
Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics
Inc.
bioM?rieux SA
Invivoscribe
Inc.
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others
Market Segmentation (by Application)
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncology Companion Diagnostic Market
Overview of the regional outlook of the Oncology Companion Diagnostic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Companion Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Companion Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncology Companion Diagnostic
1.2 Key Market Segments
1.2.1 Oncology Companion Diagnostic Segment by Type
1.2.2 Oncology Companion Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY COMPANION DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Companion Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Oncology Companion Diagnostic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY COMPANION DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncology Companion Diagnostic Product Life Cycle
3.3 Global Oncology Companion Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global Oncology Companion Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncology Companion Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncology Companion Diagnostic Market Competitive Situation and Trends
3.8.1 Oncology Companion Diagnostic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncology Companion Diagnostic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY COMPANION DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 Oncology Companion Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY COMPANION DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncology Companion Diagnostic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncology Companion Diagnostic Market
5.7 ESG Ratings of Leading Companies
6 ONCOLOGY COMPANION DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Companion Diagnostic Sales Market Share by Type (2020-2025)
6.3 Global Oncology Companion Diagnostic Market Size Market Share by Type (2020-2025)
6.4 Global Oncology Companion Diagnostic Price by Type (2020-2025)
7 ONCOLOGY COMPANION DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Companion Diagnostic Market Sales by Application (2020-2025)
7.3 Global Oncology Companion Diagnostic Market Size (M USD) by Application (2020-2025)
7.4 Global Oncology Companion Diagnostic Sales Growth Rate by Application (2020-2025)
8 ONCOLOGY COMPANION DIAGNOSTIC MARKET SALES BY REGION
8.1 Global Oncology Companion Diagnostic Sales by Region
8.1.1 Global Oncology Companion Diagnostic Sales by Region
8.1.2 Global Oncology Companion Diagnostic Sales Market Share by Region
8.2 Global Oncology Companion Diagnostic Market Size by Region
8.2.1 Global Oncology Companion Diagnostic Market Size by Region
8.2.2 Global Oncology Companion Diagnostic Market Size Market Share by Region
8.3 North America
8.3.1 North America Oncology Companion Diagnostic Sales by Country
8.3.2 North America Oncology Companion Diagnostic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncology Companion Diagnostic Sales by Country
8.4.2 Europe Oncology Companion Diagnostic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncology Companion Diagnostic Sales by Region
8.5.2 Asia Pacific Oncology Companion Diagnostic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncology Companion Diagnostic Sales by Country
8.6.2 South America Oncology Companion Diagnostic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncology Companion Diagnostic Sales by Region
8.7.2 Middle East and Africa Oncology Companion Diagnostic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLOGY COMPANION DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Companion Diagnostic by Region(2020-2025)
9.2 Global Oncology Companion Diagnostic Revenue Market Share by Region (2020-2025)
9.3 Global Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncology Companion Diagnostic Production
9.4.1 North America Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.4.2 North America Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncology Companion Diagnostic Production
9.5.1 Europe Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.5.2 Europe Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncology Companion Diagnostic Production (2020-2025)
9.6.1 Japan Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.6.2 Japan Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncology Companion Diagnostic Production (2020-2025)
9.7.1 China Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.7.2 China Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agilent Technologies
10.1.1 Agilent Technologies Basic Information
10.1.2 Agilent Technologies Oncology Companion Diagnostic Product Overview
10.1.3 Agilent Technologies Oncology Companion Diagnostic Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Inc.
10.2.1 Inc. Basic Information
10.2.2 Inc. Oncology Companion Diagnostic Product Overview
10.2.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.2.4 Inc. Business Overview
10.2.5 Inc. SWOT Analysis
10.2.6 Inc. Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Oncology Companion Diagnostic Product Overview
10.3.3 Illumina Oncology Companion Diagnostic Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Inc.
10.4.1 Inc. Basic Information
10.4.2 Inc. Oncology Companion Diagnostic Product Overview
10.4.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.4.4 Inc. Business Overview
10.4.5 Inc. Recent Developments
10.5 Qiagen N.V.
10.5.1 Qiagen N.V. Basic Information
10.5.2 Qiagen N.V. Oncology Companion Diagnostic Product Overview
10.5.3 Qiagen N.V. Oncology Companion Diagnostic Product Market Performance
10.5.4 Qiagen N.V. Business Overview
10.5.5 Qiagen N.V. Recent Developments
10.6 Thermo Fisher Scientific Inc.
10.6.1 Thermo Fisher Scientific Inc. Basic Information
10.6.2 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Overview
10.6.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Market Performance
10.6.4 Thermo Fisher Scientific Inc. Business Overview
10.6.5 Thermo Fisher Scientific Inc. Recent Developments
10.7 F. Hoffmann-La Roche Ltd.
10.7.1 F. Hoffmann-La Roche Ltd. Basic Information
10.7.2 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Overview
10.7.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Market Performance
10.7.4 F. Hoffmann-La Roche Ltd. Business Overview
10.7.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.8 ARUP Laboratories
10.8.1 ARUP Laboratories Basic Information
10.8.2 ARUP Laboratories Oncology Companion Diagnostic Product Overview
10.8.3 ARUP Laboratories Oncology Companion Diagnostic Product Market Performance
10.8.4 ARUP Laboratories Business Overview
10.8.5 ARUP Laboratories Recent Developments
10.9 Abbott
10.9.1 Abbott Basic Information
10.9.2 Abbott Oncology Companion Diagnostic Product Overview
10.9.3 Abbott Oncology Companion Diagnostic Product Market Performance
10.9.4 Abbott Business Overview
10.9.5 Abbott Recent Developments
10.10 Myriad Genetics
10.10.1 Myriad Genetics Basic Information
10.10.2 Myriad Genetics Oncology Companion Diagnostic Product Overview
10.10.3 Myriad Genetics Oncology Companion Diagnostic Product Market Performance
10.10.4 Myriad Genetics Business Overview
10.10.5 Myriad Genetics Recent Developments
10.11 Inc.
10.11.1 Inc. Basic Information
10.11.2 Inc. Oncology Companion Diagnostic Product Overview
10.11.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.11.4 Inc. Business Overview
10.11.5 Inc. Recent Developments
10.12 bioM?rieux SA
10.12.1 bioM?rieux SA Basic Information
10.12.2 bioM?rieux SA Oncology Companion Diagnostic Product Overview
10.12.3 bioM?rieux SA Oncology Companion Diagnostic Product Market Performance
10.12.4 bioM?rieux SA Business Overview
10.12.5 bioM?rieux SA Recent Developments
10.13 Invivoscribe
10.13.1 Invivoscribe Basic Information
10.13.2 Invivoscribe Oncology Companion Diagnostic Product Overview
10.13.3 Invivoscribe Oncology Companion Diagnostic Product Market Performance
10.13.4 Invivoscribe Business Overview
10.13.5 Invivoscribe Recent Developments
10.14 Inc.
10.14.1 Inc. Basic Information
10.14.2 Inc. Oncology Companion Diagnostic Product Overview
10.14.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.14.4 Inc. Business Overview
10.14.5 Inc. Recent Developments
11 ONCOLOGY COMPANION DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global Oncology Companion Diagnostic Market Size Forecast
11.2 Global Oncology Companion Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Companion Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Companion Diagnostic Market Size Forecast by Region
11.2.4 South America Oncology Companion Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncology Companion Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Oncology Companion Diagnostic Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Oncology Companion Diagnostic by Type (2026-2033)
12.1.2 Global Oncology Companion Diagnostic Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Oncology Companion Diagnostic by Type (2026-2033)
12.2 Global Oncology Companion Diagnostic Market Forecast by Application (2026-2033)
12.2.1 Global Oncology Companion Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global Oncology Companion Diagnostic Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncology Companion Diagnostic
1.2 Key Market Segments
1.2.1 Oncology Companion Diagnostic Segment by Type
1.2.2 Oncology Companion Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY COMPANION DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Companion Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Oncology Companion Diagnostic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY COMPANION DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncology Companion Diagnostic Product Life Cycle
3.3 Global Oncology Companion Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global Oncology Companion Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncology Companion Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncology Companion Diagnostic Market Competitive Situation and Trends
3.8.1 Oncology Companion Diagnostic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncology Companion Diagnostic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY COMPANION DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 Oncology Companion Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY COMPANION DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncology Companion Diagnostic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncology Companion Diagnostic Market
5.7 ESG Ratings of Leading Companies
6 ONCOLOGY COMPANION DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Companion Diagnostic Sales Market Share by Type (2020-2025)
6.3 Global Oncology Companion Diagnostic Market Size Market Share by Type (2020-2025)
6.4 Global Oncology Companion Diagnostic Price by Type (2020-2025)
7 ONCOLOGY COMPANION DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Companion Diagnostic Market Sales by Application (2020-2025)
7.3 Global Oncology Companion Diagnostic Market Size (M USD) by Application (2020-2025)
7.4 Global Oncology Companion Diagnostic Sales Growth Rate by Application (2020-2025)
8 ONCOLOGY COMPANION DIAGNOSTIC MARKET SALES BY REGION
8.1 Global Oncology Companion Diagnostic Sales by Region
8.1.1 Global Oncology Companion Diagnostic Sales by Region
8.1.2 Global Oncology Companion Diagnostic Sales Market Share by Region
8.2 Global Oncology Companion Diagnostic Market Size by Region
8.2.1 Global Oncology Companion Diagnostic Market Size by Region
8.2.2 Global Oncology Companion Diagnostic Market Size Market Share by Region
8.3 North America
8.3.1 North America Oncology Companion Diagnostic Sales by Country
8.3.2 North America Oncology Companion Diagnostic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncology Companion Diagnostic Sales by Country
8.4.2 Europe Oncology Companion Diagnostic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncology Companion Diagnostic Sales by Region
8.5.2 Asia Pacific Oncology Companion Diagnostic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncology Companion Diagnostic Sales by Country
8.6.2 South America Oncology Companion Diagnostic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncology Companion Diagnostic Sales by Region
8.7.2 Middle East and Africa Oncology Companion Diagnostic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLOGY COMPANION DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Companion Diagnostic by Region(2020-2025)
9.2 Global Oncology Companion Diagnostic Revenue Market Share by Region (2020-2025)
9.3 Global Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncology Companion Diagnostic Production
9.4.1 North America Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.4.2 North America Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncology Companion Diagnostic Production
9.5.1 Europe Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.5.2 Europe Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncology Companion Diagnostic Production (2020-2025)
9.6.1 Japan Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.6.2 Japan Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncology Companion Diagnostic Production (2020-2025)
9.7.1 China Oncology Companion Diagnostic Production Growth Rate (2020-2025)
9.7.2 China Oncology Companion Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agilent Technologies
10.1.1 Agilent Technologies Basic Information
10.1.2 Agilent Technologies Oncology Companion Diagnostic Product Overview
10.1.3 Agilent Technologies Oncology Companion Diagnostic Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Inc.
10.2.1 Inc. Basic Information
10.2.2 Inc. Oncology Companion Diagnostic Product Overview
10.2.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.2.4 Inc. Business Overview
10.2.5 Inc. SWOT Analysis
10.2.6 Inc. Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Oncology Companion Diagnostic Product Overview
10.3.3 Illumina Oncology Companion Diagnostic Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Inc.
10.4.1 Inc. Basic Information
10.4.2 Inc. Oncology Companion Diagnostic Product Overview
10.4.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.4.4 Inc. Business Overview
10.4.5 Inc. Recent Developments
10.5 Qiagen N.V.
10.5.1 Qiagen N.V. Basic Information
10.5.2 Qiagen N.V. Oncology Companion Diagnostic Product Overview
10.5.3 Qiagen N.V. Oncology Companion Diagnostic Product Market Performance
10.5.4 Qiagen N.V. Business Overview
10.5.5 Qiagen N.V. Recent Developments
10.6 Thermo Fisher Scientific Inc.
10.6.1 Thermo Fisher Scientific Inc. Basic Information
10.6.2 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Overview
10.6.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Market Performance
10.6.4 Thermo Fisher Scientific Inc. Business Overview
10.6.5 Thermo Fisher Scientific Inc. Recent Developments
10.7 F. Hoffmann-La Roche Ltd.
10.7.1 F. Hoffmann-La Roche Ltd. Basic Information
10.7.2 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Overview
10.7.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Market Performance
10.7.4 F. Hoffmann-La Roche Ltd. Business Overview
10.7.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.8 ARUP Laboratories
10.8.1 ARUP Laboratories Basic Information
10.8.2 ARUP Laboratories Oncology Companion Diagnostic Product Overview
10.8.3 ARUP Laboratories Oncology Companion Diagnostic Product Market Performance
10.8.4 ARUP Laboratories Business Overview
10.8.5 ARUP Laboratories Recent Developments
10.9 Abbott
10.9.1 Abbott Basic Information
10.9.2 Abbott Oncology Companion Diagnostic Product Overview
10.9.3 Abbott Oncology Companion Diagnostic Product Market Performance
10.9.4 Abbott Business Overview
10.9.5 Abbott Recent Developments
10.10 Myriad Genetics
10.10.1 Myriad Genetics Basic Information
10.10.2 Myriad Genetics Oncology Companion Diagnostic Product Overview
10.10.3 Myriad Genetics Oncology Companion Diagnostic Product Market Performance
10.10.4 Myriad Genetics Business Overview
10.10.5 Myriad Genetics Recent Developments
10.11 Inc.
10.11.1 Inc. Basic Information
10.11.2 Inc. Oncology Companion Diagnostic Product Overview
10.11.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.11.4 Inc. Business Overview
10.11.5 Inc. Recent Developments
10.12 bioM?rieux SA
10.12.1 bioM?rieux SA Basic Information
10.12.2 bioM?rieux SA Oncology Companion Diagnostic Product Overview
10.12.3 bioM?rieux SA Oncology Companion Diagnostic Product Market Performance
10.12.4 bioM?rieux SA Business Overview
10.12.5 bioM?rieux SA Recent Developments
10.13 Invivoscribe
10.13.1 Invivoscribe Basic Information
10.13.2 Invivoscribe Oncology Companion Diagnostic Product Overview
10.13.3 Invivoscribe Oncology Companion Diagnostic Product Market Performance
10.13.4 Invivoscribe Business Overview
10.13.5 Invivoscribe Recent Developments
10.14 Inc.
10.14.1 Inc. Basic Information
10.14.2 Inc. Oncology Companion Diagnostic Product Overview
10.14.3 Inc. Oncology Companion Diagnostic Product Market Performance
10.14.4 Inc. Business Overview
10.14.5 Inc. Recent Developments
11 ONCOLOGY COMPANION DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global Oncology Companion Diagnostic Market Size Forecast
11.2 Global Oncology Companion Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Companion Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Companion Diagnostic Market Size Forecast by Region
11.2.4 South America Oncology Companion Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncology Companion Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Oncology Companion Diagnostic Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Oncology Companion Diagnostic by Type (2026-2033)
12.1.2 Global Oncology Companion Diagnostic Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Oncology Companion Diagnostic by Type (2026-2033)
12.2 Global Oncology Companion Diagnostic Market Forecast by Application (2026-2033)
12.2.1 Global Oncology Companion Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global Oncology Companion Diagnostic Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Companion Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global Oncology Companion Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Oncology Companion Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Oncology Companion Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Oncology Companion Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Companion Diagnostic as of 2024)
Table 10. Global Market Oncology Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Oncology Companion Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Oncology Companion Diagnostic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Oncology Companion Diagnostic Sales by Type (K Units)
Table 26. Global Oncology Companion Diagnostic Market Size by Type (M USD)
Table 27. Global Oncology Companion Diagnostic Sales (K Units) by Type (2020-2025)
Table 28. Global Oncology Companion Diagnostic Sales Market Share by Type (2020-2025)
Table 29. Global Oncology Companion Diagnostic Market Size (M USD) by Type (2020-2025)
Table 30. Global Oncology Companion Diagnostic Market Size Share by Type (2020-2025)
Table 31. Global Oncology Companion Diagnostic Price (USD/Unit) by Type (2020-2025)
Table 32. Global Oncology Companion Diagnostic Sales (K Units) by Application
Table 33. Global Oncology Companion Diagnostic Market Size by Application
Table 34. Global Oncology Companion Diagnostic Sales by Application (2020-2025) & (K Units)
Table 35. Global Oncology Companion Diagnostic Sales Market Share by Application (2020-2025)
Table 36. Global Oncology Companion Diagnostic Market Size by Application (2020-2025) & (M USD)
Table 37. Global Oncology Companion Diagnostic Market Share by Application (2020-2025)
Table 38. Global Oncology Companion Diagnostic Sales Growth Rate by Application (2020-2025)
Table 39. Global Oncology Companion Diagnostic Sales by Region (2020-2025) & (K Units)
Table 40. Global Oncology Companion Diagnostic Sales Market Share by Region (2020-2025)
Table 41. Global Oncology Companion Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 42. Global Oncology Companion Diagnostic Market Size Market Share by Region (2020-2025)
Table 43. North America Oncology Companion Diagnostic Sales by Country (2020-2025) & (K Units)
Table 44. North America Oncology Companion Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Oncology Companion Diagnostic Sales by Country (2020-2025) & (K Units)
Table 46. Europe Oncology Companion Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Oncology Companion Diagnostic Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Oncology Companion Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 49. South America Oncology Companion Diagnostic Sales by Country (2020-2025) & (K Units)
Table 50. South America Oncology Companion Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Oncology Companion Diagnostic Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Oncology Companion Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 53. Global Oncology Companion Diagnostic Production (K Units) by Region(2020-2025)
Table 54. Global Oncology Companion Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Oncology Companion Diagnostic Revenue Market Share by Region (2020-2025)
Table 56. Global Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Agilent Technologies Basic Information
Table 62. Agilent Technologies Oncology Companion Diagnostic Product Overview
Table 63. Agilent Technologies Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies SWOT Analysis
Table 66. Agilent Technologies Recent Developments
Table 67. Inc. Basic Information
Table 68. Inc. Oncology Companion Diagnostic Product Overview
Table 69. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Inc. Business Overview
Table 71. Inc. SWOT Analysis
Table 72. Inc. Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Oncology Companion Diagnostic Product Overview
Table 75. Illumina Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Inc. Basic Information
Table 80. Inc. Oncology Companion Diagnostic Product Overview
Table 81. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Inc. Business Overview
Table 83. Inc. Recent Developments
Table 84. Qiagen N.V. Basic Information
Table 85. Qiagen N.V. Oncology Companion Diagnostic Product Overview
Table 86. Qiagen N.V. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Qiagen N.V. Business Overview
Table 88. Qiagen N.V. Recent Developments
Table 89. Thermo Fisher Scientific Inc. Basic Information
Table 90. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Overview
Table 91. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Thermo Fisher Scientific Inc. Business Overview
Table 93. Thermo Fisher Scientific Inc. Recent Developments
Table 94. F. Hoffmann-La Roche Ltd. Basic Information
Table 95. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Overview
Table 96. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. F. Hoffmann-La Roche Ltd. Business Overview
Table 98. F. Hoffmann-La Roche Ltd. Recent Developments
Table 99. ARUP Laboratories Basic Information
Table 100. ARUP Laboratories Oncology Companion Diagnostic Product Overview
Table 101. ARUP Laboratories Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. ARUP Laboratories Business Overview
Table 103. ARUP Laboratories Recent Developments
Table 104. Abbott Basic Information
Table 105. Abbott Oncology Companion Diagnostic Product Overview
Table 106. Abbott Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Abbott Business Overview
Table 108. Abbott Recent Developments
Table 109. Myriad Genetics Basic Information
Table 110. Myriad Genetics Oncology Companion Diagnostic Product Overview
Table 111. Myriad Genetics Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Myriad Genetics Business Overview
Table 113. Myriad Genetics Recent Developments
Table 114. Inc. Basic Information
Table 115. Inc. Oncology Companion Diagnostic Product Overview
Table 116. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Inc. Business Overview
Table 118. Inc. Recent Developments
Table 119. bioM?rieux SA Basic Information
Table 120. bioM?rieux SA Oncology Companion Diagnostic Product Overview
Table 121. bioM?rieux SA Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. bioM?rieux SA Business Overview
Table 123. bioM?rieux SA Recent Developments
Table 124. Invivoscribe Basic Information
Table 125. Invivoscribe Oncology Companion Diagnostic Product Overview
Table 126. Invivoscribe Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Invivoscribe Business Overview
Table 128. Invivoscribe Recent Developments
Table 129. Inc. Basic Information
Table 130. Inc. Oncology Companion Diagnostic Product Overview
Table 131. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Inc. Business Overview
Table 133. Inc. Recent Developments
Table 134. Global Oncology Companion Diagnostic Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Oncology Companion Diagnostic Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Oncology Companion Diagnostic Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Oncology Companion Diagnostic Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Oncology Companion Diagnostic Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Oncology Companion Diagnostic Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Oncology Companion Diagnostic Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Oncology Companion Diagnostic Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Oncology Companion Diagnostic Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Companion Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global Oncology Companion Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Oncology Companion Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Oncology Companion Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Oncology Companion Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Companion Diagnostic as of 2024)
Table 10. Global Market Oncology Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Oncology Companion Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Oncology Companion Diagnostic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Oncology Companion Diagnostic Sales by Type (K Units)
Table 26. Global Oncology Companion Diagnostic Market Size by Type (M USD)
Table 27. Global Oncology Companion Diagnostic Sales (K Units) by Type (2020-2025)
Table 28. Global Oncology Companion Diagnostic Sales Market Share by Type (2020-2025)
Table 29. Global Oncology Companion Diagnostic Market Size (M USD) by Type (2020-2025)
Table 30. Global Oncology Companion Diagnostic Market Size Share by Type (2020-2025)
Table 31. Global Oncology Companion Diagnostic Price (USD/Unit) by Type (2020-2025)
Table 32. Global Oncology Companion Diagnostic Sales (K Units) by Application
Table 33. Global Oncology Companion Diagnostic Market Size by Application
Table 34. Global Oncology Companion Diagnostic Sales by Application (2020-2025) & (K Units)
Table 35. Global Oncology Companion Diagnostic Sales Market Share by Application (2020-2025)
Table 36. Global Oncology Companion Diagnostic Market Size by Application (2020-2025) & (M USD)
Table 37. Global Oncology Companion Diagnostic Market Share by Application (2020-2025)
Table 38. Global Oncology Companion Diagnostic Sales Growth Rate by Application (2020-2025)
Table 39. Global Oncology Companion Diagnostic Sales by Region (2020-2025) & (K Units)
Table 40. Global Oncology Companion Diagnostic Sales Market Share by Region (2020-2025)
Table 41. Global Oncology Companion Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 42. Global Oncology Companion Diagnostic Market Size Market Share by Region (2020-2025)
Table 43. North America Oncology Companion Diagnostic Sales by Country (2020-2025) & (K Units)
Table 44. North America Oncology Companion Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Oncology Companion Diagnostic Sales by Country (2020-2025) & (K Units)
Table 46. Europe Oncology Companion Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Oncology Companion Diagnostic Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Oncology Companion Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 49. South America Oncology Companion Diagnostic Sales by Country (2020-2025) & (K Units)
Table 50. South America Oncology Companion Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Oncology Companion Diagnostic Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Oncology Companion Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 53. Global Oncology Companion Diagnostic Production (K Units) by Region(2020-2025)
Table 54. Global Oncology Companion Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Oncology Companion Diagnostic Revenue Market Share by Region (2020-2025)
Table 56. Global Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Oncology Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Agilent Technologies Basic Information
Table 62. Agilent Technologies Oncology Companion Diagnostic Product Overview
Table 63. Agilent Technologies Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies SWOT Analysis
Table 66. Agilent Technologies Recent Developments
Table 67. Inc. Basic Information
Table 68. Inc. Oncology Companion Diagnostic Product Overview
Table 69. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Inc. Business Overview
Table 71. Inc. SWOT Analysis
Table 72. Inc. Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Oncology Companion Diagnostic Product Overview
Table 75. Illumina Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Inc. Basic Information
Table 80. Inc. Oncology Companion Diagnostic Product Overview
Table 81. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Inc. Business Overview
Table 83. Inc. Recent Developments
Table 84. Qiagen N.V. Basic Information
Table 85. Qiagen N.V. Oncology Companion Diagnostic Product Overview
Table 86. Qiagen N.V. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Qiagen N.V. Business Overview
Table 88. Qiagen N.V. Recent Developments
Table 89. Thermo Fisher Scientific Inc. Basic Information
Table 90. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Overview
Table 91. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Thermo Fisher Scientific Inc. Business Overview
Table 93. Thermo Fisher Scientific Inc. Recent Developments
Table 94. F. Hoffmann-La Roche Ltd. Basic Information
Table 95. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Overview
Table 96. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. F. Hoffmann-La Roche Ltd. Business Overview
Table 98. F. Hoffmann-La Roche Ltd. Recent Developments
Table 99. ARUP Laboratories Basic Information
Table 100. ARUP Laboratories Oncology Companion Diagnostic Product Overview
Table 101. ARUP Laboratories Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. ARUP Laboratories Business Overview
Table 103. ARUP Laboratories Recent Developments
Table 104. Abbott Basic Information
Table 105. Abbott Oncology Companion Diagnostic Product Overview
Table 106. Abbott Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Abbott Business Overview
Table 108. Abbott Recent Developments
Table 109. Myriad Genetics Basic Information
Table 110. Myriad Genetics Oncology Companion Diagnostic Product Overview
Table 111. Myriad Genetics Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Myriad Genetics Business Overview
Table 113. Myriad Genetics Recent Developments
Table 114. Inc. Basic Information
Table 115. Inc. Oncology Companion Diagnostic Product Overview
Table 116. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Inc. Business Overview
Table 118. Inc. Recent Developments
Table 119. bioM?rieux SA Basic Information
Table 120. bioM?rieux SA Oncology Companion Diagnostic Product Overview
Table 121. bioM?rieux SA Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. bioM?rieux SA Business Overview
Table 123. bioM?rieux SA Recent Developments
Table 124. Invivoscribe Basic Information
Table 125. Invivoscribe Oncology Companion Diagnostic Product Overview
Table 126. Invivoscribe Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Invivoscribe Business Overview
Table 128. Invivoscribe Recent Developments
Table 129. Inc. Basic Information
Table 130. Inc. Oncology Companion Diagnostic Product Overview
Table 131. Inc. Oncology Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Inc. Business Overview
Table 133. Inc. Recent Developments
Table 134. Global Oncology Companion Diagnostic Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Oncology Companion Diagnostic Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Oncology Companion Diagnostic Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Oncology Companion Diagnostic Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Oncology Companion Diagnostic Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Oncology Companion Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Oncology Companion Diagnostic Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Oncology Companion Diagnostic Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Oncology Companion Diagnostic Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Oncology Companion Diagnostic Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Oncology Companion Diagnostic Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncology Companion Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Companion Diagnostic Market Size (M USD), 2024-2033
Figure 5. Global Oncology Companion Diagnostic Market Size (M USD) (2020-2033)
Figure 6. Global Oncology Companion Diagnostic Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Companion Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncology Companion Diagnostic Product Life Cycle
Figure 13. Oncology Companion Diagnostic Sales Share by Manufacturers in 2024
Figure 14. Global Oncology Companion Diagnostic Revenue Share by Manufacturers in 2024
Figure 15. Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Oncology Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncology Companion Diagnostic Revenue in 2024
Figure 18. Industry Chain Map of Oncology Companion Diagnostic
Figure 19. Global Oncology Companion Diagnostic Market PEST Analysis
Figure 20. Global Oncology Companion Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncology Companion Diagnostic Market Share by Type
Figure 27. Sales Market Share of Oncology Companion Diagnostic by Type (2020-2025)
Figure 28. Sales Market Share of Oncology Companion Diagnostic by Type in 2024
Figure 29. Market Size Share of Oncology Companion Diagnostic by Type (2020-2025)
Figure 30. Market Size Share of Oncology Companion Diagnostic by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncology Companion Diagnostic Market Share by Application
Figure 33. Global Oncology Companion Diagnostic Sales Market Share by Application (2020-2025)
Figure 34. Global Oncology Companion Diagnostic Sales Market Share by Application in 2024
Figure 35. Global Oncology Companion Diagnostic Market Share by Application (2020-2025)
Figure 36. Global Oncology Companion Diagnostic Market Share by Application in 2024
Figure 37. Global Oncology Companion Diagnostic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncology Companion Diagnostic Sales Market Share by Region (2020-2025)
Figure 39. Global Oncology Companion Diagnostic Market Size Market Share by Region (2020-2025)
Figure 40. North America Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Oncology Companion Diagnostic Sales Market Share by Country in 2024
Figure 43. North America Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncology Companion Diagnostic Market Size Market Share by Country in 2024
Figure 45. U.S. Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncology Companion Diagnostic Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Oncology Companion Diagnostic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncology Companion Diagnostic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncology Companion Diagnostic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Oncology Companion Diagnostic Sales Market Share by Country in 2024
Figure 53. Europe Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncology Companion Diagnostic Market Size Market Share by Country in 2024
Figure 55. Germany Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncology Companion Diagnostic Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Oncology Companion Diagnostic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncology Companion Diagnostic Market Size Market Share by Region in 2024
Figure 68. China Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncology Companion Diagnostic Sales and Growth Rate (K Units)
Figure 79. South America Oncology Companion Diagnostic Sales Market Share by Country in 2024
Figure 80. South America Oncology Companion Diagnostic Market Size and Growth Rate (M USD)
Figure 81. South America Oncology Companion Diagnostic Market Size Market Share by Country in 2024
Figure 82. Brazil Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncology Companion Diagnostic Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Oncology Companion Diagnostic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncology Companion Diagnostic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncology Companion Diagnostic Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncology Companion Diagnostic Production Market Share by Region (2020-2025)
Figure 103. North America Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 106. China Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Oncology Companion Diagnostic Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Oncology Companion Diagnostic Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Oncology Companion Diagnostic Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Oncology Companion Diagnostic Market Share Forecast by Type (2026-2033)
Figure 111. Global Oncology Companion Diagnostic Sales Forecast by Application (2026-2033)
Figure 112. Global Oncology Companion Diagnostic Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Oncology Companion Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Companion Diagnostic Market Size (M USD), 2024-2033
Figure 5. Global Oncology Companion Diagnostic Market Size (M USD) (2020-2033)
Figure 6. Global Oncology Companion Diagnostic Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Companion Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncology Companion Diagnostic Product Life Cycle
Figure 13. Oncology Companion Diagnostic Sales Share by Manufacturers in 2024
Figure 14. Global Oncology Companion Diagnostic Revenue Share by Manufacturers in 2024
Figure 15. Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Oncology Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncology Companion Diagnostic Revenue in 2024
Figure 18. Industry Chain Map of Oncology Companion Diagnostic
Figure 19. Global Oncology Companion Diagnostic Market PEST Analysis
Figure 20. Global Oncology Companion Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncology Companion Diagnostic Market Share by Type
Figure 27. Sales Market Share of Oncology Companion Diagnostic by Type (2020-2025)
Figure 28. Sales Market Share of Oncology Companion Diagnostic by Type in 2024
Figure 29. Market Size Share of Oncology Companion Diagnostic by Type (2020-2025)
Figure 30. Market Size Share of Oncology Companion Diagnostic by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncology Companion Diagnostic Market Share by Application
Figure 33. Global Oncology Companion Diagnostic Sales Market Share by Application (2020-2025)
Figure 34. Global Oncology Companion Diagnostic Sales Market Share by Application in 2024
Figure 35. Global Oncology Companion Diagnostic Market Share by Application (2020-2025)
Figure 36. Global Oncology Companion Diagnostic Market Share by Application in 2024
Figure 37. Global Oncology Companion Diagnostic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncology Companion Diagnostic Sales Market Share by Region (2020-2025)
Figure 39. Global Oncology Companion Diagnostic Market Size Market Share by Region (2020-2025)
Figure 40. North America Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Oncology Companion Diagnostic Sales Market Share by Country in 2024
Figure 43. North America Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncology Companion Diagnostic Market Size Market Share by Country in 2024
Figure 45. U.S. Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncology Companion Diagnostic Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Oncology Companion Diagnostic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncology Companion Diagnostic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncology Companion Diagnostic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Oncology Companion Diagnostic Sales Market Share by Country in 2024
Figure 53. Europe Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncology Companion Diagnostic Market Size Market Share by Country in 2024
Figure 55. Germany Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncology Companion Diagnostic Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Oncology Companion Diagnostic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncology Companion Diagnostic Market Size Market Share by Region in 2024
Figure 68. China Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncology Companion Diagnostic Sales and Growth Rate (K Units)
Figure 79. South America Oncology Companion Diagnostic Sales Market Share by Country in 2024
Figure 80. South America Oncology Companion Diagnostic Market Size and Growth Rate (M USD)
Figure 81. South America Oncology Companion Diagnostic Market Size Market Share by Country in 2024
Figure 82. Brazil Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncology Companion Diagnostic Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Oncology Companion Diagnostic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncology Companion Diagnostic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncology Companion Diagnostic Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncology Companion Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Oncology Companion Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncology Companion Diagnostic Production Market Share by Region (2020-2025)
Figure 103. North America Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 106. China Oncology Companion Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Oncology Companion Diagnostic Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Oncology Companion Diagnostic Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Oncology Companion Diagnostic Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Oncology Companion Diagnostic Market Share Forecast by Type (2026-2033)
Figure 111. Global Oncology Companion Diagnostic Sales Forecast by Application (2026-2033)
Figure 112. Global Oncology Companion Diagnostic Market Share Forecast by Application (2026-2033)
